BackMaquia Capital Acquisition - Warrants (05/05/2026) Overview

Maquia Capital Acquisition - Warrants (05/05/2026) Total Liabilities

Maquia Capital Acquisition - Warrants (05/05/2026)'s total liabilities is $9.6M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.56M
↓ 3.24% YoYΔ $-320558.00 vs prior year quarter

Peer trimmed avg / median

Loading

Maquia Capital Acquisition - Warrants (05/05/2026) Total Liabilities History

Loading

Maquia Capital Acquisition - Warrants (05/05/2026) vs. peers: Total Liabilities Comparison

Loading

Maquia Capital Acquisition - Warrants (05/05/2026) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Maquia Capital Acquisition - Warrants (05/05/2026) (MAQCW) FAQ

As of the most recent data (September 2024), MAQCW shows a total liabilities of $9.6M. That compares with $9.9M in the prior-year period — down 3.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MAQCW's total liabilities is now $9.6M (was $9.9M) — a 3.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Maquia Capital Acquisition - Warrants (05/05/2026) is outperforming or lagging.

Tracking MAQCW's total liabilities over time shows whether Maquia Capital Acquisition - Warrants (05/05/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $9.6M That compares with $9.9M in the prior-year period — down 3.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Maquia Capital Acquisition - Warrants (05/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $9.6M) with ownership activity and broader fundamentals.